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Abstract
Introduction: In contrast to the defence mechanism of RNA interference (RNAi) in plants and invertebrates, its role in the
innate response to virus infection of mammals is a matter of debate. Since RNAi has a well-established role in controlling
infection of the alphavirus Sindbis virus (SINV) in insects, we have used this virus to investigate the role of RNAi in SINV
infection of human cells.
Results: SINV AR339 and TR339-GFP were adapted to grow in HEK293 cells. Deep sequencing of small RNAs (sRNAs) early in
SINV infection (4 and 6 hpi) showed low abundance (0.8%) of viral sRNAs (vsRNAs), with no size, sequence or location
specific patterns characteristic of Dicer products nor did they possess any discernible pattern to ascribe to a specific RNAi
biogenesis pathway. This was supported by multiple variants for each sequence, and lack of hot spots along the viral
genome sequence. The abundance of the best defined vsRNAs was below the limit of Northern blot detection. The
adaptation of the virus to HEK293 cells showed little sequence changes compared to the reference; however, a SNP in E1
gene with a preference from G to C was found. Deep sequencing results showed little variation of expression of cellular
microRNAs (miRNAs) at 4 and 6 hpi compared to uninfected cells. Twelve miRNAs exhibiting some minor differential
expression by sequencing, showed no difference in expression by Northern blot analysis.
Conclusions: We show that, unlike SINV infection of invertebrates, generation of Dicer-dependent svRNAs and change in
expression of cellular miRNAs were not detected as part of the Human response to SINV.
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Introduction
Small RNAs (sRNAs) are 20–30 nt non-coding RNAs that can
regulate gene expression in a sequence-specific manner through a
mechanism known as RNA interference (RNAi). Their biogenesis
includes the processing of long double stranded RNA (dsRNA)
into small RNAs (sRNAs) by Dicer. The sRNAs bind to
homologous mRNAs and suppress gene expression. Importantly,
in plants, insects and nematodes, RNAi can also serve as an innate
immune response against viruses, as dsRNA produced by viruses
as intermediates of replication is processed by a RNA Induced
Silencing Complex (RISC) into small interfering RNAs (siRNAs)
to target complementary viral mRNAs for destruction. It is still a
matter of debate if RNAi plays a role in innate immunity in
mammals [1,2] because the sRNAs were only isolated at low
concentration [3] and it is unclear whether the observed fragments
are DICER dependent or not [4]. However, there is recent
evidence that RNAi has a functional antiviral role in mouse
embryonic stem cells and in tissues of suckling mice infected with
Nodamura virus lacking an RNAi suppressor, although vsRNAs
were reduced or absent in differentiated cells [5,6]. Mammalian
cells respond to virus infection through recognition of the dsRNA
by two DEAD/box helicases, RIG-I and MDA-5. Activation of
these helicases leads to induction of interferon and interferon
stimulated genes (ISGs) which act in diverse ways to eliminate the
virus [7–10] and it is thought that this interferon response has
supplanted antiviral RNAi in higher organisms [1]. The compo-
nents and function of the RNAi machinery are conserved in
mammalian cells, although unlike plants and invertebrates, only
one Dicer-like enzyme has been identified in human and its role in
processing dsRNA replication-intermediates of mammalian viruses
into vsRNAs is unclear [4,11]. The development of high
throughput sequencing technologies made possible the detection
of low abundance sRNAs, facilitating the in depth study of
vsRNAs. An initial study using deep sequencing from infection of a
broad range of animal cells with six different RNA and DNA
viruses showed the existence of some vsRNAs and changes in host
miRNA expression [3].
SINV is an alphavirus in the Togovirus family which has a
single stranded positive sense RNA genome of ,12,000 nucleo-
tides. The capsid protein enclosing the RNA is surrounded by a
lipid bilayer with two transmembrane glycoproteins, E1 and E2.
dsRNA is produced during replication, using the negative strand
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as a template for new copies of the genome. The first two-thirds of
the genome contain the genes for the four nonstructural proteins,
nsP1 to nsP4, which catalyze the replication and transcription of
the viral RNAs [12]. The structural proteins, capsid and two
envelope proteins are encoded in the latter one-third of the
genome translated from a 26S subgenomic RNA. SINV is an
arbovirus with a broad range specificity, infecting both insect and
human cells and it is well established that in mosquitoes, RNAi is
used as the primary antiviral defence. SINV-derived sRNAs have
been detected and formed more than 10% of the sequenced
sRNAs [13,14]; recently, alphavirus-derived piRNA-like sRNAs
have been found in mosquitoes [15,16]. In addition, a novel class
of endogenous siRNAs was discovered in Aedes aegypti mosqui-
toes infected by SINV. It is hypothesised that suppression of SINV
replication by the mosquito RNAi is essential for the virus to
survive in the mosquito vector [17]. However, little is known about
RNAi in the regulation of SINV infection of mammalian cells.
In this study we looked for the presence of vsRNAs during a
time course of SINV infection of human embryonic kidney 293
cells (HEK 293) and the changes in cellular miRNA profiles by
high throughput sequencing. We found that the majority of reads
derived from the human and not from the virus genome. In
addition, based on the size class and complexity distributions of
vsRNAs, we did not find any evidence that the reads could derive
from Dicer processing. Furthermore, cellular miRNA expression
profiles remained unchanged following SINV infection, and we
conclude that modulation of the RNAi system is not an immediate
early response to SINV infection of human cells.
Materials and Methods
Cells and Viruses
All cells were maintained at 37uC in 5% CO2. HEK 293 cells
derived from human embryonic kidney isolate were grown in
DMEM-Glutamax (Invitrogen, Dulbecco/Vogt modified Eagle’s
medium) with 5% non-essential amino acids, 10% FCS and
penicillin-streptomycin. Baby Hamster Kidney (BHK) cells were
maintained in DMEM/F-12 (Invitrogen) with 5% non-essential
amino acids, 10% FCS and penicillin-streptomycin.
Sindbis Virus (SINV) AR339 was received from John Fazakerly,
The Pirbright Laboratory, UK. TR339 infectious cDNA clone
was from William Klimstra, University of Pittsburgh, Pittsburgh,
PA. Rabbit anti-Sindbis virus polyclonal antibody was a gift from
Sondra Schlessinger, Washington University Medical School St
Louis, MO.
Sindbis virus (SINV) production
SINV A339V stocks were grown in BHK cells and then virus
was adapted to grow in HEK 293 cells by up to three serial
passages to make high titre HEK 293 stocks. Virus growth was
slower in HEK 293 cells compared to BHK cells, with a
replication time of 8hpi at each passage, and viral titres increased.
Only low passage number virus was used to avoid overproduction
of defective interfering particles and to limit sequence changes in
the adapted virus. The final viral sequence used for inoculation
was assembled using reads from the Illumina sequencing. Virus
protein E2 was detected by Western blot and immuno-staining
using an anti SINV antibody, and by using RT-PCR with SINV
specific primers. AR339 SINV was concentrated by polyethylene
glycol precipitation. (PEG-IT; System Biosciences) PEG-IT was
added to the media in a 1:5 dilution and incubated at 4uC
overnight. The precipitate was collected by centrifugation with
3000 g for 30 minutes at 4uC, and resuspended in OPTIMEM
(Invitrogen).
RNA isolation
Trizol (Invitrogen) was used to extract SINV RNA, both for
total RNA isolation and sRNA. For isolation of sRNA the samples
were incubated at 220uC in isopropanol overnight. The mirVana
(Ambion) kit was used according to the manufacturer’s instructions
to isolate total RNA for Illumina Solexa sequencing of sRNA.
High Throughput Illumina Solexa sequencing
High-throughput sequencing was carried out as previously
described [18] using v1.5 of the Illumina adapters. The total RNA
was isolated, reverse transcribed with v1.5 adapters and amplified
(18 cycles). The 90–110 nt (75 nt adapter-adapter) band was
excised, corresponding to 15 to 35 nt RNA sequences and the
sRNA library was sent to Baseclear (www.baseclear.nl) for
sequencing on the Illumina/Solexa GA II [19,20].
Northern blotting
Total RNA was isolated from samples using Trizol (Invitrogen).
Electrophoresis, transfer and blotting were performed as previ-
ously described [21]. After chemical crosslinking, the membranes
were hybridised overnight in ULTRAhyb-Oligo hybridisation
buffer (Ambion) containing either c-P32 ATP labelled primer
probes, or c-P32 ATP locked nucleic acid (LNA) probes (incubated
at 37uC and 62uC respectively), or with a P32-CTP labelled
riboprobes (incubated at 64uC), and imaged using Fuji phosphor-
imaging screen. The sequences used are
SINV genomic and subgenomic (position 7568–7631): GTAT-
TAGTCAGATGAAATGTACTATGCTGACTATTTAGGAC-
CACCGTAGAGATGCTTTATTTCC, LNA probe sequence
(position 6614-6633): GGATAGATTCGTCATGGACA. U6
(TCATCCTTGCGCAGGGGCCA) was used as loading control.
The miRNAs selected for validation and the sequences used as
probes are as follows:
mir 29a:TAACCGATTTCAGATGGTGCTA; mir 34:
ACAACCAGCTAAGACACTGCCA;
mir 10:ACAAATTCGGTTCTACAGGGTA;
mir 19:TCAGTTTTGCATGGATTTGCACA; let 7:AACTA-
TACAATCTACTACCTCA;
mir 92:GGAGGCCGGGACGAGTGCAATA; mir 378:
GCCTTCTGACTCCAAGTCCAGT; mir196: CCCAACAA-
CATGAAACTACCTA;
mir 197: GCTGGGTGGAGAAGGTGGTGAA.
Bioinformatics methods
For the analysis we used the GenBank reference sequence for
the Sindbis virus gi|9790313|ref|NC_001547.1 [22] and the
latest available sequence for the Human genome (hg19) [23].
The preliminary analysis of the sequenced libraries was
conducted using the UEA sRNA Workbench [24]. The adaptor
removal, quality check and genome matching were conducted as
described in [25]. The accepted reads (the entire length of the
reads) were mapped with no mis-matches against the human
genome, or with up to 2 mis-matches against the SINV genome.
The normalization was conducted using the proportional scaling
approach, ‘‘reads per million’’ (RPM) [26]. The identification of
miRNAs was conducted using miRCat [27], with standard
parameters for human samples and miRprof using all mature
and precursor sequences of miRNAs deposited in miRBase [28] as
input. The statistical analysis of the properties of sRNAs was
conducted in R using the standard stats package.
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Results
Sindbis virus is efficiently replicated in human HEK 293
cells
The role of RNAi in the defence of mammalian cells against
RNA viruses is not yet established. SINV is a valuable research
model of a positive stranded RNA virus, which cycles through
arthropod and non-human vertebrate hosts. SINV AR339 is an
attenuated laboratory strain, first isolated from mosquitoes, which
has been adapted to replicate in BHK cells, and which does not
cause disease in humans [29].
Virus generated in BHK cells was adapted through two passages
through HEK 293 cells. Virus showed a slower kinetics of
replication and secretion compared to BHK cells with virus
secretion beginning by 8hpi, and an increased viral titre was
obtained with each passage. The SINV genome has been shown to
have lower rates of evolution than other RNA viruses [30] and
adaptation to various cells has been shown to result from
mutations in E2 to enhance binding and infection [31].
RNA was isolated at different time points (2, 4, 6, 8hpi) in
HEK293 cells and virus replication was detected by Northern
blotting with SINV specific probes. The presence of full length
transcripts at 49S and the sub genomic transcript at 26 S
demonstrated efficient replication starting between 2 and 4hpi
and increasing through 8hpi (Figure 1A). During the same time
course the envelope glycoprotein E2 was observed by immuno-
fluorescence at 4hpi and increasing through 8hpi (Figure 1B)
demonstrating that SINV effectively and rapidly infected and
replicated in HEK293 cells. Based on this information the time
points for sRNA sequencing were chosen at 4hpi and 6hpi at times
when the highest level of dsRNA replication intermediates as
substrates for Dicer can be observed. After 8hpi virus is secreted
into the media (increased intracellular virus production, figure 1B)
and the apoptotic process initiates after approximately 24hpi (data
not shown). Therefore an earlier time point, 6hpi, was chosen to
avoid any chance of RNA degradation due to initiation of
apoptosis.
High-throughput sequencing shows viral sRNAs in very
low abundance in SINV infected HEK 293 cells
RNA was isolated from SINV inoculated cells at 0, 4 and 6hpi.
cDNA libraries were generated for the sRNA content of the cells
and sequenced using Illumina GA II, which yielded between
29.1million (M) and 30.5 M reads per sample. The size class and
complexity (defined as the ratio of non-redundant to redundant
reads [25]) distributions for all reads for which the adapter
sequence was identified is presented in figure 2A. We observed a
preference for sequences of lengths 22–23 nt, which are also
characterised by a low complexity indicating a low number of
unique reads with high abundance.
Next, the sequences were mapped to the human and SINV
genomes, respectively, using PatMaN [32] revealing that more
than 83% of sequences mapped to the human genome (HUM
reads), and 0.8% sequences mapped to the SINV genome (SINV
reads). The size class and complexity distributions for all reads are
shown in Figure 2A. The size class and complexity distributions of
the HUM reads (figure 2B) are similar to the overall distributions,
preserving the properties of the 22–23 nt reads. In addition, a low
complexity for the HUM 22mers indicates miRNAs – subplot B2
(subsequent analysis revealed that more than 60% of these reads
correspond to known miRNAs). The SINV reads (figure 2C)
showed an even distribution for all size classes, suggesting that
these reads are not Dicer-derived. This hypothesis is also
supported by the uniformity of the complexity index (i.e. the
complexity was similar for all size classes in the 4hpi and 6hpi
samples). The size class distribution and complexity analyses were
also conducted separately on each strand and the conclusions were
the same (figure S1). No conclusion was based on the complexity
distribution for the mock sample because of the extremely low
number of SINV reads (20 reads) present. In addition the ratios of
vsRNAs mapping to positive and negative strand were 4:1 at 4hpi
and 20:1 at 6hpi, similar to what would be expected at these time
points for the ratio of positive and negative RNAs [33,34].
To investigate whether the passage resulted in changes to the
reference sequence of the viral inoculum, meaning that some
vsRNAs may be missed, even if 2 mismatches were allowed, we
Figure 1. Infection and replication of SINV in HEK293 cells. (A). Northern blot showing SINV full length genome (49 S) and subgenomic (26 S)
positive strand RNA rapidly accumulates in HEK293 cells from 2hpi and increasing through 8 hpi. The probe consisted of P32 end-labelled primers at
positions 7568–7631 in the genome. The 28 S and 18 S RNA bands stained with ethidium bromide are displayed to demonstrate equal loading. (B)
Immunostaining of SINV in HEK293 cells using rabbit anti E2 glycoprotein antibody detected SINV E2 translation increasing over 4, 6 and 8 hpi with
over 95% of cells infected with well-defined replication centres (visualised with an anti-rabbit secondary antibody labelled with Alexa488 and nuclei
are shown with DAPI).
doi:10.1371/journal.pone.0084070.g001
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assembled the vsRNAs at each time point into contigs which were
then compared to the reference sequence (figure 3A). The
sequence of the adapted virus was similar to the NCBI reference
sequence; in 4hpi and 6hpi one significant nucleotide polymor-
phism (SNP) was detected in E1 at position 10393. This SNP was a
change from G to C or A (figure S2) which led to a valine to
leucine or isoleucine substitution. This is a conservative change
which would not be likely to affect protein function. In addition
there were no changes in sRNA size class distribution or
complexity between the adapted and reference genomes.
To investigate the hypothesis, that the SINV reads are not
Dicer-derived reads, we analysed the distribution of expression
(sum of abundances of SINV reads for all positions) for the whole
genome (figure 3B) and conducted a x2 analysis applied on the size
class distribution compared to a random uniform distribution, for
windows of length 100 nt (figure 3C). The purpose of identifying
regions which show a preference for a size class is that these
regions are likely to be excised in a precise manner through the
RNAi pathway [35]. This analysis revealed highly significant
regions (i.e. regions for which the size class distribution was
significantly different from a random uniform distribution, the p
Value was below 0.05 in both 4hpi and 6hpi samples), and regions
for which the size class distribution was very similar to a random
uniform distribution (p Value above 0.7, in both 4hpi and 6hpi
samples). We attempted the validation of reads coming from the
highly significant regions, but their abundance was found to be
below the detection limit of Northern blot analysis using primers
or LNA probes (data not shown). The detection limit for the
miRNA northern blots (shown in figure 4B) was approximated to
100 normalized reads per million; the maximum abundance of
specific fragments matching to SINV is below 70. Increasing the
number of mis-matches between the reads and the reference
genome (0, 1, 2, 3 mis-matches) did not change the conclusions.
To better understand the interaction between the virus and the
host, we computed the number of reads that could match to both
the virus genome and the human genome. 5% of the SINV reads
matched to both genomes. All of the reads were low abundance
and many variants (sequences with high similarity and less than 4
mis-matches to the considered read) were present on the SINV
alignment, suggesting that the reads have a higher probability to
be produced by the virus RNA, rather than the human genome.
Figure 3B shows the lack of hotspots, which suggest the absence of
specific cleavage of the viral genome and the lack of location
specificity on the SINV genome. In addition, the uniform
distribution of each size class for reads on both strands supports
the hypothesis that the reads are not Dicer derived fragments.
SINV infection does not modulate the cellular miRNA
expression
Since the majority of reads mapped to the human genome
(.8 M and .6 M reads in the first two samples and in the third,
respectively), we also investigated the changes induced by the virus
infection in the cellular sRNAome. First, we identified miRNAs
using miRCat [27] and mirProf [24]; out of the 110 predicted
miRNAs, 92 (including variants) were conserved and 18 were
novel. To further investigate the sRNAome changes, other
properties of miRNA loci were analysed. First, using all human
miRNAs from miRBase [28] for which we could identify at least 3
reads in the samples, the distribution of signal across the
precursors was analysed. For all miRNAs more than 90% of the
signal was consistently concentrated on the miRNA and miRNA*,
in all three samples. Next the size class distribution on the
precursors was analysed using a x2 test (the approach was similar to
Figure 2. Size class and complexity distributions of sequencing reads. Size distribution and complexity are shown for (A) all reads, (B) reads
mapping to the Human genome, (C) reads mapping to the SINV genome. Subplots A1, B1 and C1 show the read number for 21–24 mers at 0, 4 and
6hpi. Subplots A2, B2 and C2 show the complexity for each size class from 17–27 mers, where the complexity is the ratio of non-redundant reads to
redundant reads.
doi:10.1371/journal.pone.0084070.g002
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the one used for the analysis of the whole SINV genome). The
approach was applicable since the distribution of pre-miRNA
lengths shows little variation around the 100 nt mark, which was
used for the SINV genome. Under the assumption of random
uniform distribution, all of the pre-miRNAs had significantly
different size class distributions, biased on 22mers. The distribu-
tions for samples 4 hpi and 6 hpi were statistically the same as for
the 0 hpi sample, suggesting no influence of the virus infection to
modulate the miRNA expression (figure 4A). The scatterplot on
annotated miRNAs shows that they display little variation between
the 0 hpi, 4hpi and 6 hpi time points. Although the variation was
small, we selected twelve miRNAs, showing the most difference in
expression by deep sequencing (Figure 4A), as candidates for
Northern blot analysis; in addition, these miRNAs have been
linked to antiviral immunity [36–47].
Northern blot validation of the sequencing results (Figure 4B)
was carried out on HEK293 cells which were infected with SINV
AR339 and SINV TR339 (an infectious clone of the same virus) in
biological triplicates at moi of 8; total RNA was isolated at 0, 4,
and 6 hpi. Three microRNAs were under detection limit and nine
showed no changes in expression levels confirming the conclusions
from sequencing.
These results show that the Sindbis virus infection does not
change miRNA expression in HEK293 cells at a time when
miRNAs may regulate an innate immune response or affect viral
replication [13].
Discussion
This study investigated the role of RNAi during SINV infection
in mammalian cells, in the light of the well-established role of
RNAi in SINV infection of insect vectors [13,14,46].
To date several modes of action of RNAi as a response to viral
infection have been proposed [2]: (1) RNAi produces svRNAs that
can target the virus genome (or transcripts in the case of DNA
viruses), (2) the viral genome encodes miRNA-like regions that are
processed by RNAi into miRNAs which can in turn target the
genes of the host, (3) the host genome encodes miRNAs which can
modulate viral replication through RNAi and (4) viral infection
can influence the expression of cellular miRNAs. The effect of
RNAi can therefore be antiviral or beneficial to the virus.
An example of the antiviral effect of the RNAi machinery,
which illustrates the first mode of action, is the systemic RNAi
response against SINV in Drosophila [46]. The second mode of
action is illustrated by the herpes virus family and other large DNA
Figure 3. Analysis of SINVmatching reads indicate degradation. (A) Nucleotide variation across the genome (x axis) at 0, 4 and 6 hpi on both
positive and negative strands is indicated by the number of unique sRNAs (0 to 300 and 0 to 2300, respectively) which vary at a given position (y
axis). This analysis indicates a high similarity of the Sindbis variants present in the cell to the reference sequence. The open reading frames are
indicated by black boxes at the top. (B) Variation of expression level (log2 scale) for SINV matching reads. The figure shows the distribution of viral
reads along the SINV genome (x axis). Positive values on y axis indicate the abundance of reads mapping to the positive strand of the virus, negative
values indicate the abundance of reads mapping to the negative strand. Black represents the 4hpi reads, grey represents the 6hpi reads. (C) Variation
of p Value presented on the y axis for a x2 significance test on the size class distribution compared to a random uniform distribution for windows of
length 100 nt along the SINV genome (x axis). Black represents 4hpi and grey represents 6hpi sRNA samples.
doi:10.1371/journal.pone.0084070.g003
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viruses which encode miRNAs that target cellular innate and
acquired immunity factors [36]. For example, miRNAs encoded
by EBV target the pro-apototic factor PUMA, miRNAs encoded
by KSHV down regulate MyD88; and miRNAs encoded by
HCMV inhibit RANTES expression [36,37,44]. The third mode
of action is illustrated by Hepatitis C Virus, for which the liver-
specific miR-122 has been shown to have a stimulating effect on
viral replication [42]. EBV infection is an example of the fourth
mode of action (viral infection modulates cellular miRNAs
expression). EBV strongly induces miR155 in B cells to promote
cell transformation [39].
In this context, we studied sRNAs during SINV infection of
mammalian cells to understand in which of these categories SINV
can be classified. Sequencing showed that there were no svRNAs
in the 20-25 nt range which could indicate the processing of the
dsRNA virus replication intermediate by the RNAi machinery.
This would suggest that there is no self targeting of viral RNA.
This is in contrast to SINV infection in mosquito cells where SINV
is a substrate for RNAi [13,38] and svRNAs prevented viral spread
between cells in Drosophila [46]. In mosquitoes variations in levels
of Ago2, DICER2 and other components of RISC were observed
during virus infection, indicating that the virus can modulate the
RNAi system [13]. In this study we cannot rule out if there are
changes in AGO2, DICER and other RISC components at
protein level.
In addition, the distribution of 20–25 nt fragments mapping to
the viral genome indicated that there are no viral miRNAs
encoded in the viral genome that could affect gene expression of
either host or virus. Viral miRNAs have been well documented in
DNA viruses, such as herpes viruses and adenoviruses [40], but
viral miRNAs have not been described for RNA viruses except for
the retrovirus bovine leukemia virus (BLV) [45].
In addition, our sequencing results showed that host miRNAs
were not differentially expressed in SINV infected cells and this
was confirmed by Northern blot. We chose as candidates those
miRNAs that have been linked to anti-viral immunity. MiRNA
29a has already been linked to several defences against pathogens.
It is shown to regulate the immune response to intracellular
Figure 4. Human miRNA expression profiles remain unchanged during early SINV infection (0, 4 and 6phi). (A) Scatter plots of miRNA
expression levels indicate no significant change in expression in HEK293 cells between 0 and 4 hpi (top panel) and 4 and 6 hpi (bottom panel). x and y
axes show the normalised expression levels of the miRNAs (log2 scale). (B) Northern blot validation of candidate miRNAs in SINV AR339 and infectious
clone TR339 indicate no change in expression. The Northern blots are biological triplicates. The equal loading is shown by U6.
doi:10.1371/journal.pone.0084070.g004
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bacterial infection through IFNc modulation [48].The level of
miR29 increases 50-fold in A549 cells in response to influenza
infection, which leads to IFNl and COX2 up-regulation [49]. In
addition, miR-29 down regulates the expression of Nef protein of
HIV-1, and it interferes with HIV-1 replication [50]. miR378 was
also shown to be targeting HIV-1 genes [41]. mir34 was shown to
be an important modulator of innate immune response through
the regulation of IFNb expression [47]. Deep sequencing data of
Pseudorabies virus showed that the large latency transcript (LLT)
functions as a primary microRNA precursor (pri-miRNA)
encoding 11 distinct miRNAs in the PRV genome [51]. KSHV
encodes 17 miRs, derived from 12 pre-miRs, with one regulating
the NF-kB pathway by reducing the expression of IkBa protein,
an inhibitor of the NF-kB complex [52]. miR19 and let7 are
important regulators of inflammatory responses as they upregulate
NF-kB activity[53]. Let7 also modulates the innate immunity
through the regulation of IFNb expression [48]. The miR17/92
cluster has been shown to regulate Epstein-Barr virus gene
expression [54]. miR196 can effectively repress hepatitis C virus
gene expression and replication [55]. miR197 targets the tumour
suppressor protein FUS1 [56]. Moreover, this mode of action has
been associated with some RNA viruses, for example the
picornavirus enterovirus 71 (EV71) activates transcription of
miR-141, which in turn suppresses translation of the cap-binding
protein eIF4E in order to inhibit cap dependent translation [43].
Although we found that SINV infection did not up-regulate host
miRNAs, it does not preclude pre-existing cellular miRNAs
influencing SINV replication, as in the case of the RNA virus
HCV where the liver specific miR-122 stimulates viral translation
[42]. It is possible that SINV-induced changes in endogenous
miRNAs occur only in its arthropod host species, such as
mosquitoes [15,17] and its nonhuman vertebrate host.
Conclusions
Our work adds to the understanding of interaction between the
alphavirus SINV and its human host through RNAi. We conclude
that the svRNAs detected by deep sequencing were not generated
by Dicer. The svRNAs may be random degradation products or
the viral RNA may be specifically targeted by the cell but at
present cannot be ascribed to a specific degradation pathway.
Although we know that interferon is not induced by SINV, at least
at early time points [57], RNase L could be a candidate via 29, 59-
oligodenylate synthetase OAS to generate these degradation
products [58]. Host miRNA profiles remained unchanged during
the early stages of the infection and we conclude that they do not
contribute to the response against SINV infection. In light of
recent studies [5,6] one possibility is that SINV encodes a potent
inhibitor of RNAi.
Supporting Information
Figure S1 Size class and complexity distributions of
reads matching to SINV genome with up to 2 mis-
matches (2 mm), positive strand (A) and negative strand (B)
shown separately for 0, 4 and 6 hpi. There is no preference for a
size class in the redundant and non-redundant distributions and
the complexity (varying between 0 and 1) remains unchanged.
(TIFF)
Figure S2 Single nucleotide polymorphism (SNP) ob-
served in E1 during viral replication. The number of unique
sRNAs with mutation compared to the SINV reference are
presented on the Y axis for all four nucleotides. The SNP changes
G to C or A, but never a T and the corresponding amino-acid
changes from valine (GTC) to leucine (CTC) or isoleucine (ATC)
in E1.
(TIF)
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